IP Library Granted Patent US 9,783,847
Granted Patent B2
US 9,783,847 · App. 14/723,332 · Granted Oct 10, 2017

Nucleic acid constructs and methods of use

Inventor: Mark S. Chee (Encinitas, CA)
Assignee: PROGNOSYS BIOSCIENCES, INC.
C12Q1/6869C12Q1/6806C12Q1/6809C12Q1/6827C12Q1/6834C12Q1/6874C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,783,847
App. No.
14/723,332
Filed
May 27, 2015
Granted
Oct 10, 2017
Kind
B2
Art Unit
1636
USPC
435/91.2
Abstract

The present invention provides oligonucleotide constructs, sets of such oligonucleotide constructs, and methods of using such oligonucleotide constructs to provide validated sequences or sets of validated sequences corresponding to desired ROIs. Such validated ROIs and constructs containing these have a wide variety of uses, including in synthetic biology, quantitative nucleic acid analysis, polymorphism and/or mutation screening, and the like.

Claims (40)

1. A set of nucleic acid constructs from an individual, wherein

a) each construct of the set comprises:

a naturally occurring nucleic acid region of interest (ROI) from the individual;

at least one unique identifier attached to the ROI that distinguishes the construct from other constructs in the set with a same ROI, wherein the at least one unique identifier is not part of its attached ROI; and

at least one amplification site; and

b) the set of constructs comprises: (i) at least two constructs with the same ROI and different unique identifiers, and (ii) two or more different ROIs.

2. The set of claim 1 , wherein one or more of the constructs comprise two or more amplification sites flanking the ROI and the unique identifier.

3. The set of claim 1 , wherein one or more of the constructs comprise a single amplification site adjacent to the ROI and the unique identifier.

4. The set of claim 1 , wherein one or more of the constructs comprise one or more excision sites.

5. The set of claim 4 , wherein one or more of the constructs comprise at least two excision sites flanking the ROI.

6. The set of claim 4 , wherein one or more of the constructs comprise a single excision site adjacent to the ROI.

7. The set of claim 1 , wherein one or more of the constructs are immobilized on a solid support.

8. The set of claim 7 , wherein the solid support comprises a bead.

9. The set of claim 1 , wherein the set comprises at least five constructs with the same ROI and different unique identifiers.

10. The set of claim 1 , wherein the set comprises at least five constructs with the same ROI, different unique identifiers, and at least one excision site.

11. The set of claim 1 , wherein one or more of the unique identifiers comprise a degenerate nucleic acid sequence.

12. The set of claim 1 , wherein the at least one unique identifier comprises at least 10 nucleotides.

13. The set of claim 1 , wherein the ROI comprises DNA.

14. The set of claim 1 , wherein the ROI comprises RNA.

15. The set of claim 13 , wherein the DNA is genomic DNA.

16. The set of claim 1 , wherein one or more of the constructs is double-stranded.

17. The set of claim 1 , wherein one or more of the constructs is single-stranded.

18. The set of claim 1 , wherein one or more of the constructs comprise at least two unique identifier sequences.

19. The set of claim 2 , wherein the two or more amplification sites are different from one another.

20. The set of claim 2 , wherein the two or more amplification sites are the same.

21. The set of claim 2 , wherein the amplification site that is opposite to the unique identifier with respect to the ROI is separate from an adjacent excision site.

22. The set of claim 2 , wherein the amplification site that is opposite to the unique identifier with respect to the ROI comprises an excision site.

23. The set of claim 1 , wherein the at least one amplification site comprises a universal priming site.

24. The set of claim 1 , wherein the ROI comprises a rare sequence variant, a low-frequency mutation, a minor allelic variant, a polymorphism, a mutation, or a haplotype.

25. The set of claim 1 , wherein the unique identifier is from a pre-defined set of sequences.

26. The set of claim 1 , wherein the unique identifier is from a degenerate set of sequences.

27. The set of claim 1 , wherein at least one construct of the set of constructs is enriched.

28. The set of claim 1 , wherein each construct comprises two unique identifier sequences.

29. The set of claim 28 , wherein the two unique identifiers are attached to one end of the ROI.

30. A set of nucleic acid constructs from an individual, wherein

a) each construct of the set comprises:

a naturally occurring nucleic acid region of interest (ROI) from the individual;

a unique identifier attached to each end of the ROI, wherein the combination of identifiers on each end of a particular ROI distinguishes the construct from other constructs in the set with a same ROI, wherein the identifiers are not part of its attached ROI; and

at least one amplification site; and

b) the set of constructs comprises: (i) at least two constructs with the same ROI and different unique identifiers, and (ii) two or more different ROIs.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jul 7, 2016
From: PROGNOSYS BIOSCIENCES, INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039276/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2015
From: CHEE, MARK S.
To: PROGNOSYS BIOSCIENCES, INC.
Reel/Frame 036212/0682 →
Continuity (3)
Division 13266568
Provisional Application 61174442 · Apr 30, 2009
Related Publication 20160024576A1 · Jan 28, 2016